scholarly article | Q13442814 |
P2093 | author name string | Qing Lu | |
Li Li | |||
Bin Zhao | |||
Chen-Ying Liu | |||
Kun-Liang Guan | |||
Lloyd H Wang | |||
Qunying Lei | |||
P2860 | cites work | Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation | Q24290939 |
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP) | Q24293710 | ||
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control | Q24299106 | ||
Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation | Q24300596 | ||
Tumor suppressor LATS1 is a negative regulator of oncogene YAP | Q24304725 | ||
TEAD mediates YAP-dependent gene induction and growth control | Q24336045 | ||
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach | Q24633776 | ||
Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases. | Q52015849 | ||
The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. | Q52100108 | ||
Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms. | Q52704046 | ||
Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway | Q81088455 | ||
The human tumour suppressor LATS1 is activated by human MOB1 at the membrane | Q83287887 | ||
Expression of Yes-associated protein in common solid tumors | Q24657592 | ||
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon | Q24682018 | ||
The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1 | Q28116287 | ||
Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains | Q28212001 | ||
salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines | Q28219379 | ||
A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells | Q28238594 | ||
The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP | Q28266862 | ||
The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version | Q28281214 | ||
Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP) | Q28287783 | ||
Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein | Q28306685 | ||
YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation | Q28507494 | ||
Angiomotin regulates visceral endoderm movements during mouse embryogenesis | Q28587014 | ||
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression | Q28591557 | ||
YAP1 increases organ size and expands undifferentiated progenitor cells | Q28592519 | ||
Crumbs regulates Salvador/Warts/Hippo signaling in Drosophila via the FERM-domain protein Expanded | Q28752559 | ||
Elucidation of a universal size-control mechanism in Drosophila and mammals | Q29618935 | ||
The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis | Q29619851 | ||
hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts | Q29620457 | ||
Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma | Q33611696 | ||
YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway | Q33644875 | ||
The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded | Q33934781 | ||
Control of cell proliferation and apoptosis by mob as tumor suppressor, mats | Q34402685 | ||
p130-angiomotin associates to actin and controls endothelial cell shape | Q34517933 | ||
The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila | Q34559232 | ||
The bantam microRNA is a target of the hippo tumor-suppressor pathway | Q34562924 | ||
Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells | Q34731285 | ||
The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis | Q36336754 | ||
Multiple microalterations detected at high frequency in oral cancer | Q38441119 | ||
Transcriptional output of the Salvador/warts/hippo pathway is controlled in distinct fashions in Drosophila melanogaster and mammalian cell lines | Q39827808 | ||
The FERM-domain protein Expanded regulates Hippo pathway activity via direct interactions with the transcriptional activator Yorkie | Q39872336 | ||
A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells | Q39991840 | ||
Characterization of the interface between normal and transformed epithelial cells | Q42450915 | ||
Phosphorylation-independent repression of Yorkie in Fat-Hippo signaling. | Q42625092 | ||
Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway | Q44591663 | ||
Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. | Q46433336 | ||
Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila | Q47072038 | ||
Mob as tumor suppressor is activated at the cell membrane to control tissue growth and organ size in Drosophila | Q47072497 | ||
Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. | Q48364922 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Angiomotin | Q4763281 |
hippo signaling | Q5768379 | ||
Angiomotin-like 1 | Q21981186 | ||
P304 | page(s) | 51-63 | |
P577 | publication date | 2011-01-01 | |
P1433 | published in | Genes & Development | Q1524533 |
P1476 | title | Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein | |
P478 | volume | 25 |